Mr. Kirk Dorius serves as CEO and General Counsel for Atom Mines specializing in production of stable Ytterbium-176 needed to produce the radioisotope Lutetium-177 for radiotherapies. Mr. Dorius has been an entrepreneur and consultant in the nuclear medicine and nuclear energy industries since 2010 and previously worked as a patent attorney with national firms and as a mechanical engineer with a missile defense contractor. He also served as president of the Pointsman Foundation, a nonprofit organization advancing domestic production and use of stable isotopes and radioisotopes for a range of medical treatments, diagnostics, and research.
Mr. Dorius has particular expertise in isotope separation, molten salt reactors, and intellectual property law. He studied mechanical engineering at Utah State University and patent law at the University of New Hampshire. Atom Mines has received a CPRIT grant to scale up production of 176-Yb for prostate cancer therapies using Magnetically Activated and Guided Isotope Separation (MAGIS) technology developed by Dr. Mark Raizen at The University of Texas at Austin.
Sessions: